BioNTech SE (BNTX) Total Non-Current Liabilities (2018 - 2025)
BioNTech SE's Total Non-Current Liabilities history spans 8 years, with the latest figure at $724.2 million for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 13.82% to $724.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $724.2 million, a 13.82% increase, with the full-year FY2025 number at $702.9 million, up 10.47% from a year prior.
- Total Non-Current Liabilities hit $724.2 million in Q4 2025 for BioNTech SE, down from $749.7 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for BNTX hit a ceiling of $1.5 billion in Q2 2025 and a floor of $278.4 million in Q4 2022.
- Historically, Total Non-Current Liabilities has averaged $639.9 million across 5 years, with a median of $620.8 million in 2021.
- Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 237.3% in 2021 and later plummeted 53.47% in 2022.
- Tracing BNTX's Total Non-Current Liabilities over 5 years: stood at $521.1 million in 2021, then tumbled by 46.57% to $278.4 million in 2022, then soared by 166.6% to $742.3 million in 2023, then dropped by 14.29% to $636.2 million in 2024, then increased by 13.82% to $724.2 million in 2025.
- Business Quant data shows Total Non-Current Liabilities for BNTX at $724.2 million in Q4 2025, $749.7 million in Q3 2025, and $1.5 billion in Q2 2025.